Jason Lettmann, CHIEF EXECUTIVE OFFICER at ALX ONCOLOGY HOLDINGS INC (ALXO), bought 163,396 shares at $1.08 ($176K) on 2025-09-17, disclosed to the SEC on 2025-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.07 | 21,070 | $23K | 12.8% |
| 2 | $1.08 | 71,163 | $77K | 43.6% |
| 3 | $1.08 | 71,163 | $77K | 43.6% |
| Total | $1.08 avg | 163,396 | $176K | 100% |
| Filing → |
| ALXO | SELL | 2025-08-19 | $2K | — | Filing → |
| ALXO | SELL | 2025-02-21 | $2K | — | Filing → |
| ALXO | BUY | 2024-03-18 | $50K | — | Filing → |